Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-20T03:36:22.967Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST)

Published online by Cambridge University Press:  29 April 2005

E. W. G. Weber ,
R. Slappendel ,
Y. Hémon ,
S. Mähler ,
T. Dalén ,
E. Rouwet ,
J. van Os ,
A. Vosmaer  and
P. ven der Ark
E. W. G. Weber
Affiliation:
Sint Maartenskliniek, Nijmegen, The Netherlands Present address: Catharina Hospital, Eindhoven, The Netherlands
R. Slappendel
Affiliation:
Sint Maartenskliniek, Nijmegen, The Netherlands
Y. Hémon
Affiliation:
Hôpital Ste-Marguerite, Marseille, France
S. Mähler
Affiliation:
Kreiskrankenhaus, Langenau, Germany
T. Dalén
Affiliation:
Norrlands Universitetssjukhus, Umeå, Sweden
E. Rouwet
Affiliation:
Medisch Spectrum Twente, Enschede, The Netherlands
J. van Os
Affiliation:
Maasland Ziekenhuis, Sittard, The Netherlands
A. Vosmaer
Affiliation:
Ikazia Ziekenhuis, Rotterdam, The Netherlands
P. ven der Ark
Affiliation:
Environ Netherlands B.V., Zeist, The Netherlands
Get access

Abstract

Summary

Background and objective: Preoperative epoetin alfa administration decreases transfusion requirements and may reduce transfusion complications, such as postoperative infection due to immune suppression and thus hospitalization time. This study examined the impact of preoperative epoetin alfa administration on postoperative recovery and infection rate.

Methods: In an open randomized controlled multicentre trial in patients undergoing orthopaedic surgery, the effects of preoperative administration of epoetin alfa vs. routine care were compared in six countries. Haemoglobin (Hb) values, transfusions, time to ambulation, time to discharge, infections and safety were evaluated in patients with preoperative Hb concentrations 10–13g dL−1 (on-treatment population: epoetin n = 460; control n = 235), from study entry until 4–6 weeks after surgery. Outcome was also compared in patients with and without transfusion.

Results: Epoetin-treated patients had higher Hb values from the day of surgery until discharge (P < 0.001) and lower transfusion rates (12% vs. 46%; P < 0.001). Epoetin treatment delivered no significant effect on postoperative recovery (time to ambulation, time to discharge and infection rate). However, the time to ambulation (3.8 ± 4.0 vs. 3.1 ± 2.2 days; P < 0.001) and the time to discharge (12.9 ± 6.4 vs. 10.2 ± 5.0 days; P < 0.001) was longer in the transfused than in the non-transfused patients. Side-effects in both groups were comparable.

Conclusions: Epoetin alfa increases perioperative Hb concentration in mild-to-moderately anaemic patients and thus reduces transfusion requirements. Patients receiving blood transfusions require a longer hospitalization than non-transfused patients.

Keywords

ARTHROPLASTY REPLACEMENT HIP, ARTHROPLASTY REPLACEMENT KNEEBLOOD TRANSFUSION, autologous, allogeneicERYTHROPOIETIN, RECOMBINANT, epoetin alfaHAEMOGLOBINHOSPITALIZATION, length of staySURGICAL WOUND INFECTION
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 22 , Issue 4 , April 2005 , pp. 249 - 257
Copyright
2005 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rosencher N, Kerkkamp H, Macheras G, et al. Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459–469.Google Scholar
Marquet RL, Hoynck van Papendrecht MA, Busch OR, Jeekel J. Blood donation leads to a decrease in natural killer cell activity: a study in normal blood donors and cancer patients. Transfusion 1993; 33: 368–373.Google Scholar
Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996; 82: 187–204.Google Scholar
Innerhofer P, Luz G, Spotl L, et al. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells. Transfusion 1999; 39: 1089–1096.Google Scholar
Spahn DR. Eliminating blood transfusions. New aspects and perspectives. Anesthesiology 2000; 93: 242–255.Google Scholar
Slappendel R, Weber EWG. Blood transfusions and postoperative recovery in orthopaedic surgery. The European Eprex surgery trial. Transfusion Alternatives in Transfusion Medicine 2004; 6 (1): 24–28.Google Scholar
Goldberg MA, McCutchen JW, Jove M, et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996; 25: 544–552.Google Scholar
Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81-A: 2–10.Google Scholar
Adamson J. Perisurgical use of epoetin alfa in orthopedic surgery patients. Semin Hematol 1996; 33: 55–58.Google Scholar
De Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC. Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop 1996; 25: 533–542.Google Scholar
Olijhoek G, Megens JG, Musto P, et al. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial. Transfusion 2001; 41: 957–963.Google Scholar
Slappendel R, Dirksen R, Weber EWG, Van der Schaaf DB. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand 2003; 74: 569–575.Google Scholar
Feagan BG, Wong CJ, Kirkley A, et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. Ann Intern Med 2000; 133: 845–854.Google Scholar
Van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJ, van de Wiel An. Iron metabolism and erythropoiesis after surgery. Br J Surg 1998; 85: 41–45.Google Scholar
Weber EWG, Slappendel R, Prins MH, Van der Schaaf DB, Durieux ME. Peroperative blood transfusions and delayed wound healing after hip replacement surgery: effects on hospitalisation. Chapter 5 in Thesis of EWG Weber, Maastricht University, The Netherlands, 2003.
Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997; 34: 34–40.Google Scholar
Houbiers JG, Van de Velde CJ, Van de Watering LM, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997; 37: 126–134.Google Scholar
Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization. A study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998; 122: 145–151.Google Scholar
Carson JL, Altman DG, Duff A, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39: 694–700.Google Scholar
Innerhofer P, Walleczek C, Luz G, et al. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999; 39: 625–632.Google Scholar
Sonnenberg FA, Gregory P, Yomtovian R, et al. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion 1999; 39: 808–817.Google Scholar
Brandi LS, Oleggini M, Lachi S, et al. Energy metabolism of surgical patients in the early postoperative period: a reappraisal. Crit Care Med 1988; 16: 18–22.Google Scholar
Brandi LS, Bertolini R, Janni A, Gioia A, Angeletti CA. Energy metabolism of thoracic surgery surgical patients in the early post operative period. Chest 1996; 109: 630–637.Google Scholar
Buick FJ, Gledhill N, Froese AB, Spriet L, Meyers EC. Effect of induced erythrocythemia on aerobic work capacity. J Appl Physiol 1980; 48: 636–642.Google Scholar